[Detection of metastases in effusions from body cavities].
作者信息
Pfitzer P
出版信息
Pathologe. 1984 Oct;5(5):252-9.
PMID:6095243
Abstract
摘要
相似文献
1
[Detection of metastases in effusions from body cavities].[体腔积液中转移灶的检测]
Pathologe. 1984 Oct;5(5):252-9.
2
Ultrastructure of the surface coat of the mesothelial and cancer cells from human effusions.人胸腔积液间皮细胞和癌细胞表面被覆物的超微结构
Mater Med Pol. 1984 Jan-Mar;16(1):3-7.
3
The surface coat of the human effusion cells.人体渗出细胞的表面被膜。
Acta Cytol. 1977 May-Jun;21(3):447-54.
4
Quantitative light microscopy of atypical mesothelial cells and malignant cells in ascitic fluid.
Anal Quant Cytol. 1982 Sep;4(3):217-20.
5
Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.豚鼠和人类肿瘤及炎性渗出液中的血管通透性因子（血管内皮生长因子）
Cancer Res. 1993 Jun 15;53(12):2912-8.
6
[Prostaglandins E in the primary tumor, metastases, and ascitic fluid of patients with ovarian cancer].[前列腺素E在卵巢癌患者原发性肿瘤、转移灶及腹水中的情况]
Biull Eksp Biol Med. 1997 Jan;123(1):83-6.
7
Normalization of the ovarian cancer microenvironment by SPARC.通过富含半胱氨酸的酸性分泌蛋白（SPARC）实现卵巢癌微环境的正常化
Mol Cancer Res. 2007 Oct;5(10):1015-30. doi: 10.1158/1541-7786.MCR-07-0001.
8
9
Immunocytochemical detection of ovarian carcinoma cells in serous effusions.浆液性积液中卵巢癌细胞的免疫细胞化学检测
Acta Cytol. 1993 May-Jun;37(3):272-9.
10
[Treatment of malignant effusions in body cavities].[体腔恶性积液的治疗]
Internist (Berl). 1997 Aug;38(8):794-804.
引用本文的文献
1
Tumor-associated antigens in effusions of malignant and benign origin.
Clin Investig. 1993 Jun;71(6):437-44. doi: 10.1007/BF00180056.
Zotero 插件